Is Crestchem a good stock to invest in?

Crestchem can be analyzed on the following key metrics - TTM P/E: 22.75 Sector P/E: 17.63 Dividend Yield: 0.6% D/E ratio: -

Crestchem Share Price

Sector: Biotechnology & Drugs

Powered by

168.90 +0.20 (0.12%)

1D
5D
1M
3M
6M
1Y
5Y
MAX

Price Range

Today’s Low 165.00

Today’s High 173.00

52 Week Low 119.70

52 Week High 350.00

Key Metrics

Market Cap (In Cr) 49.84
Beta 0.25
Div. Yield (%) 0.6
P/B 6.74
TTM P/E 22.75
Sector P/E 17.63
D/E 0
Open Price 172.95
Prev Close 168.7

View All Metrics

Crestchem Analysis

Price Analysis

1 Week

-2.61%
3 Months

-18.73%
6 Month

-33.91%
YTD

-40.05%
1 Year

31.12%

Risk Meter

60% Low risk
60% Moderate risk
60% Balanced Risk
60% High risk
60% Extreme risk

Crestchem News

These are the top stocks that promoters or insiders of the company bought during the sharp fall. (Image: Pixabay)

Premium

3 stocks that promoters bought during the market crash post election result

5 min read . 05 Jun 2024

View More News

Crestchem Financials

INCOME
BALANCE SHEET
Cashflow

DATE

Annual

Quarterly

Period
2025

Total Revenue
25.08

Selling/ General/ Admin Expenses Total
1.16

Depreciation/ Amortization
0.05

Other Operating Expenses Total
1.87

Total Operating Expense
21.85

Operating Income
3.23

Net Income Before Taxes
3.66

Net Income
2.73

Diluted Normalized EPS
9.09

Period
2024

Total Revenue
21.26

Selling/ General/ Admin Expenses Total
0.67

Depreciation/ Amortization
0.05

Other Operating Expenses Total
1.71

Total Operating Expense
18.53

Operating Income
2.73

Net Income Before Taxes
2.98

Net Income
2.15

Diluted Normalized EPS
7.15

Period
2023

Total Revenue
16.73

Selling/ General/ Admin Expenses Total
0.53

Depreciation/ Amortization
0.02

Other Operating Expenses Total
0.93

Total Operating Expense
15.93

Operating Income
0.8

Net Income Before Taxes
0.94

Net Income
0.69

Diluted Normalized EPS
2.31

Period
2022

Total Revenue
7.95

Selling/ General/ Admin Expenses Total
0.26

Depreciation/ Amortization
0.03

Other Operating Expenses Total
0.81

Total Operating Expense
7.23

Operating Income
0.72

Net Income Before Taxes
0.78

Net Income
0.57

Diluted Normalized EPS
1.89

Period
2021

Total Revenue
7.64

Selling/ General/ Admin Expenses Total
0.47

Depreciation/ Amortization
0.02

Other Operating Expenses Total
0.7

Total Operating Expense
7.01

Operating Income
0.64

Net Income Before Taxes
0.67

Net Income
0.57

Diluted Normalized EPS
1.91

Period
2020

Total Revenue
6.2

Selling/ General/ Admin Expenses Total
0.13

Depreciation/ Amortization
0.02

Other Operating Expenses Total
0.62

Total Operating Expense
5.66

Operating Income
0.55

Net Income Before Taxes
0.57

Net Income
0.44

Diluted Normalized EPS
1.48

Period
2019

Total Revenue
0.1

Selling/ General/ Admin Expenses Total
0.13

Depreciation/ Amortization
0.01

Other Operating Expenses Total
0.13

Total Operating Expense
0.28

Operating Income
-0.18

Net Income Before Taxes
-0.17

Net Income
-0.17

Diluted Normalized EPS
-0.57

View detailed financials

Forecast

Income Sheet (In Cr) Net Income Vs Revenue

Returns Metrics (In Cr) ROA Vs ROE

Forecast

Balance Sheet Asset vs Liability

Forecast

Cash Flow Operating vs Investing

Crestchem Technical

Moving Average SMA

5 Day170.7
10 Day174.14
20 Day174.42

50 Day188.39
100 Day203.51
300 Day228.28

Crestchem Peers

Price
Ratio

Name
Latest Price
Change
% Change
52W High
52W Low
Mkt. Cap

Lasa Supergenerics
10.29
0.49
5
33.49
8.52
51.55

Deccan Health Care
20.3
0.83
4.26
39.1
16
47.48

Crestchem
168.9
0.2
0.12
350
119.7
49.84

Sandu Pharmaceuticals
49.8
-0.41
-0.82
69.5
43.75
48.18

Roopa Industries
58.88
1.39
2.42
114.9
47.26
46.47

Crestchem Shareholding

Shareholding Pattern

Shareholding Trend

Shareholding(%) v/s Date

View All

Corporate Actions

Board Meeting
AGM
Dividends
Bonus
Split
Rights

Meeting Date
Purpose

28-May-25
Audited Results & Dividend

31-Mar-25
Others

12-Feb-25
Quarterly Results

21-Nov-24
Others

12-Nov-24
Quarterly Results

19-Sept-24
Others

12-Aug-24
Quarterly Results

04-Jul-24
A.G.M.

28-May-24
Audited Results & Final Dividend

30-Mar-24
Others

Meeting Date
Announced on
Purpose

24-Jan-25
17-Dec-24
POM

24-Aug-23
25-Jul-23
AGM

-
15-Jul-24
AGM

Announced on
Record Date
Ex-Dividend
Dividend Value

28-May-25
-
-
1

28-May-24
-
23-Aug-24
0.5

View All

Company Profile

ABOUT Crestchem

Industry Biotechnology & Drugs
ISIN INE293N01016
BSE Code 526269

Crestchem Limited is an India-based company, which is engaged in the business of manufacturing, marketing and exporting products derived from the newly developed field of nutraceutical ingredients, emerging from the conventional chemical, food, and pharmaceutical fields. The Company is primarily involved in the manufacturing of nutrition-chemical products. The Company is also focused on manufacturing / marketing of three kinds of product groups in the nutritional chemical field, including medium chain triglycerides (MCTs), lactose free products, and oil's and fat's water-soluble powders. The lactose free products include lactose free skimmed milk powder (LFSMP), spray dried, and complete and balanced nutrition formulations (based on the lactose free concept). The oils and fats in powder form include spray dried (water-soluble oils and fat powders), high olic sunflower oil powder, palm oil powder, coconut oil powder, aromatic oil powder on dairy base material, and dairy cream powder.

MANAGEMENT

Khyati Vyas Chief Financial Officer, Compliance Officer, Company Secretary

CRESTCHEM SUMMARY

Crestchem is trading 0.12% upper at Rs 168.90 as compared to its last closing price. Crestchem has been trading in the price range of 173.00 & 165.00. Crestchem has given -40.05% in this year & -2.61% in the last 5 days.

Crestchem has TTM P/E ratio 22.75 as compared to the sector P/E of 17.63.

The company posted a net profit of 0.61 Crores in its last quarter.

Listed peers of Crestchem include Lasa Supergenerics (5%), Deccan Health Care (4.26%), Crestchem (0.12%) etc.

Crestchem has a 32.22% promoter holding & 67.78% public holding.

FAQs about Crestchem

Crestchem is trading at 168.90 as on 27 Jun, 2025 3:28:57 PM. This is 0.12% upper as compared to its previous closing price of 168.7

The market capitalization of Crestchem is 49.84 Cr as on 27 Jun, 2025 3:28:57 PM.

The 52 wk high for Crestchem is 350.00 whereas the 52 wk low is 119.70

Crestchem can be analyzed on the following key metrics -

TTM P/E: 22.75
Sector P/E: 17.63
Dividend Yield: 0.6%
D/E ratio: -

Crestchem reported a net profit of 2.73 Cr in 2025.

Crestchem Quick Links

Equity Quick Links

Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks

Crestchem Share Price

Price Range

Key Metrics

Crestchem Analysis

Crestchem News

3 stocks that promoters bought during the market crash post election result

Crestchem Financials

Forecast

Forecast

Forecast

Crestchem Technical

Crestchem Peers

Crestchem Shareholding

Shareholding Pattern

Shareholding Trend

Corporate Actions

Company Profile

ABOUT Crestchem

MANAGEMENT

CRESTCHEM SUMMARY

FAQs about Crestchem

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue